Request a Proposal
Welcome to Rapport, containing tips, truths, news and views, blogs, tweets, articles and films covering a range of topics currently affecting Research Partnership and the pharma market research world

Selected deals for SARS-CoV-2 vaccines in late stage development

Selected deals for SARS-CoV-2 vaccines in late stage development

Did you know Canada has secured deals with all six of the leading vaccine candidates in development, as well as one domestic manufacturer? In our latest infographic, we present a selection of some of the confirmed procurement deals from higher-income countries.

read more »

  • Posted by Rachel Howard
  • October 22, 2020
  • Articles

How will COVID-19 affect uptake of vaccinations against other diseases?

How will COVID-19 affect uptake of vaccinations against other diseases?

As the world waits anxiously for a SARS-CoV-2 vaccine, Director Rachel Howard explores whether COVID-19 will help or hinder the quest to increase uptake of other vaccinations. Published in PME Magazine, October 2020

In January, as the (then unnamed) novel coronavirus started spreading across the globe, media coverage in the Western world urged people not to panic, reminding them that ‘regular’ flu posed a greater threat to their health. Now we find ourselves in October, over six months since the first lockdown, and with many countries now undergoing a ‘second wave’ of infections. With the benefit of hindsight, it might seem easy to scoff at the following quote from Dr William Schaffner, a professor of preventive medicine and health policy at Vanderbilt University Medical Center in Tennessee. “When we think about the relative danger of this new coronavirus and influenza, there’s just no comparison. Coronavirus will be a blip on the horizon in comparison. The risk is trivial.”

read more »

  • Posted by Brett Gardiner
  • September 30, 2020
  • Webinars

Keeping up with the Coronavirus: Monitoring the impact of COVID-19 on the market access landscape

Keeping up with the Coronavirus: Monitoring the impact of COVID-19 on the market access landscape

Our market access team share insights from our COVID-19 impact study and advise how biopharmaceutical companies can keep up with pricing and market access activity.

COVID-19 is causing major disruption to healthcare systems all over the world and in these difficult times it’s hard to keep up with all of the latest developments. With the landscape changing almost every day, how can we tell what impact coronavirus is really having?
 

read more »

  • Posted by Harrison Gaiger
  • September 29, 2020
  • Articles

Fake news pandemic: The rise of healthcare misinformation in the age of COVID-19

Fake news pandemic: The rise of healthcare misinformation in the age of COVID-19

Harrison Gaiger explores the Coronavirus myths and mistruths that have flooded social media and the human cost of healthcare misinformation.

In February of this year, Dr Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization (WHO) warned of a wave of false information that would impede an effective public health response to COVID-19 and create confusion and distrust among people all over the world. He claimed that we were not just fighting an epidemic but also an ‘infodemic’ – an abundance of information, some accurate some not, that would spread faster and more easily than the virus, making it difficult to identify what is true and what is false. It was just a few weeks later that Dr Adhanom Ghebreyesus announced to the world that the COVID-19 outbreak could be characterised as a global pandemic. With almost no country in the world unaffected, and with fear for the future increasing, the wave of misinformation he warned us about was in danger of becoming a tsunami.

read more »

  • Posted by Pei Li Teh & An-hwa Lee
  • September 8, 2020
  • Webinars

Digital #marcomms: How to evaluate and optimise marketing activities impacted by COVID-19

Digital #marcomms: How to evaluate and optimise marketing activities impacted by COVID-19

Our experts consider the impact the pandemic has and will continue to have on marketing in global healthcare and look at the continued shift towards digital communications as a means to engage physicians and patients.  

read more »